These are not all of the possible side effects of ORSERDU. Call your doctor for medical advice about side effects. You may report side effects to FDA at .
What are the most common side effects of Orserdu? The most common side effects of Orserdu are headache, musculoskeletal pain, fatigue, vomiting, hot flush
Orserdu. What is this drug used for? It is used to treat However, many people have no side effects or only have minor side effects.
Orserdu (elacestrant) is a brand-name oral tablet prescribed for specific types of advanced breast cancer in certain adults. As with other drugs, Orserdu can cause side effects, including muscle
Side effects - Verzenio or Orserdu. Anyone have sharp abdominal pains when on Verzenio or Orserdu? The diarrhea is one thing but I'm really
Orserdu also may cause serious side effects, including hypercholesterolemia and hypertriglyceridemia. Hypercholesterolemia means your low-
These are not all of the possible side effects of ORSERDU. Call your doctor for medical advice about side effects. You may report side effects to FDA at FDA-1088. How should I store ORSERDU? Store ORSERDU at room temperature 68℉ to 77℉ (20℃ to 25℃). Keep ORSERDU and all medicines out of the reach of children.
What Are The Side Effects Of Orserdu? Like any other cancer treatment, Orserdu can cause side effects or adverse events, some of which are severe. The mentioned EMERALD study reported adverse events (AEs) in 92% of patients who received Orserdu therapy and 86% of those who received the other treatments.
Serious side effects occurred in 12% of patients who received Orserdu. The most common serious side effects for more than 1% of patients who received Orserdu were musculoskeletal pain (chronic pain in bones, muscles, ligaments, tendons and nerves) (1.7%) and nausea (1.3%).
Comments
one of my own pet peeves, sorry
The story was awesome...
Given all the side effects of mostly untested medications I could honestly see this happening to someone since most new meds get pulled within 5 years because of the side effects.